Colleen F Reitan is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 775 shares of ALNY, which is worth approximately $348,099. The most recent transaction as insider was on Sep 09, 2025, when has been sold 18,000 shares (Common Stock) at a price of $469.51 per share, resulting in proceeds of $8,451,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 775
0% 3M change
2052.78% 12M change
Total Value Held $348,099

Colleen F Reitan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 09 2025
SELL
Open market or private sale
$8,451,180 $469.51 p/Share
18,000 Reduced 95.87%
775 Common Stock
Sep 09 2025
BUY
Exercise of conversion of derivative security
$1,811,700 $100.65 p/Share
18,000 Added 48.95%
18,775 Common Stock
May 08 2025
BUY
Grant, award, or other acquisition
-
775 Added 50.0%
775 Common Stock
Apr 16 2025
SELL
Open market or private sale
$8,382 $232.86 p/Share
36 Reduced 100.0%
0 Common Stock
Oct 17 2024
BUY
Open market or private purchase
$1,210 $302.67 p/Share
4 Added 10.0%
36 Common Stock
Aug 29 2024
BUY
Open market or private purchase
$9,152 $286.0 p/Share
32 Added 50.0%
32 Common Stock

Also insider at

MYGN
MYRIAD GENETICS INC Healthcare
CFR

Colleen F Reitan

Director
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Track Activities on ALNY